Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+179K
-
Total reported value, excl. options
-
$510M
-
Value change
-
+$9.35M
-
Put/Call ratio
-
0.86
-
Number of buys
-
68
-
Number of sells
-
-113
-
Price
-
$37.03
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2023
254 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 30.2M outstanding shares and own 45.57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.63M shares), VANGUARD GROUP INC (1.39M shares), DIMENSIONAL FUND ADVISORS LP (1.05M shares), STATE STREET CORP (756K shares), Divisadero Street Capital Management, LP (693K shares), CITADEL ADVISORS LLC (464K shares), Nuveen Asset Management, LLC (413K shares), GEODE CAPITAL MANAGEMENT, LLC (413K shares), JPMORGAN CHASE & CO (304K shares), and AMERICAN CENTURY COMPANIES INC (272K shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.